Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 5
Submit an article Journal homepage
1,988
Views
4
CrossRef citations to date
0
Altmetric
Influenza – Research Paper

Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis

Pablo Manuel Biancullia Value & Access, Sanofi Pasteur, Buenos Aires, Argentina (former)Correspondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7859-6065View further author information
ORCID Icon,
Lucile Bellierb CreativCeutical, London, UKView further author information
,
Ignacio Olivera Mangadoc Centro de Investigaciones Económicas (CINVE), Montevideo, UruguayView further author information
,
Carlos Grau Pérezc Centro de Investigaciones Económicas (CINVE), Montevideo, Uruguay;d Faculty, Universidad de la República, Montevideo, UruguayView further author information
,
Gustavo Mieresc Centro de Investigaciones Económicas (CINVE), Montevideo, UruguayView further author information
,
Luis Lazarovc Centro de Investigaciones Económicas (CINVE), Montevideo, Uruguay;d Faculty, Universidad de la República, Montevideo, UruguayView further author information
,
Audrey Petitjeane Health Economics & Value Assessment, Sanofi Pasteur Global, Lyon, FranceView further author information
,
Hugo Dibarbouref Public Affairs, Sanofi Pasteur South Cone, Montevideo, UruguayView further author information
&
Juan Guillermo Lopezg Health Economics & Outcomes Research, Sanofi Pasteur, DF, Mexico (former)View further author information
 show all
Article: 2050653 | Received 17 Sep 2021, Accepted 04 Mar 2022, Published online: 28 Mar 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Eliel Nham, Hye Seong, Hakjun Hyun, Jin Gu Yoon, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim, Eugene Kim, Leejung Choi, Jung-Min Lee & Joon Young Song. (2023) Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate. Human Vaccines & Immunotherapeutics 19:3.
Read now
Xiaoyuan Huang, Ting Fan, Li Li, Xuanxuan Nian, Jiayou Zhang, Xuefen Gao, Wei Zhao, Wei Chen, Zhaoqing Zhang, Zhihao Yao, Xixin Han, Jinrong Shi, Ying Wang, Haihe Bian, Nianmin Shi, Xinguo Li, Kai Duan, Guohua Li & Xiaoming Yang. (2022) Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial. Human Vaccines & Immunotherapeutics 18:5.
Read now

Articles from other publishers (2)

Yilin Gong, Xuelin Yao, Jin Peng, Yue Ma, Yu Fang, Kangkang Yan & Minghuan Jiang. (2023) Cost-Effectiveness and Health Impacts of Different Influenza Vaccination Strategies for Children in China. American Journal of Preventive Medicine 65:1, pages 155-164.
Crossref
Analía Urueña, Paula Micone, María Cecilia Magneres, Ian McGovern, Joaquin Mould-Quevedo, Túlio Tadeu Rocha Sarmento & Norberto Giglio. (2022) Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina. Vaccines 10:10, pages 1627.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.